| Project/Area Number |
22659061
|
|---|
| Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
General medical chemistry
|
|---|
| Research Institution | Saitama Medical University |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2010 – 2011
|
| Project Status |
Completed (Fiscal Year 2011)
|
| Budget Amount *help |
¥3,090,000 (Direct Cost: ¥2,700,000、Indirect Cost: ¥390,000)
Fiscal Year 2011: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2010: ¥1,400,000 (Direct Cost: ¥1,400,000)
|
|---|
| Keywords | 相同組換え / iPS細胞 / ウイルスベクター / 再生医療 / 多能性幹細胞 |
|---|
| Research Abstract |
In order to minimize cell culture for iPSC induction and gene repair, thus reducing the risk of introducing new mutations, we examined a strategy of simultaneous iPSC induction and gene targeting. TIG3 human fibroblasts were subjected to iPSC induction by using the Sendai virus vector, SeVp(KOSM). iPSC-like colonies were grown as a cell populationwithout cloning, and were subsequently transduced with a HDAdV targeting the HPRT locus. The gene targeting frequencies were 3-5% of chromosomal integration, which were equivalent to those with authentic human iPSCs. From the start of iPSC induction to isolation of drug-resistant colonies, it took only 6 weeks.
|
